| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10148246 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
Our findings suggest that AAÂ +Â PÂ +Â ADT is at least as effective as DOCÂ +Â ADT in reducing the risk of death in men with mHSPCÂ and better at preventing disease progression and improving QoL. The NMA provides useful insights to clinicians and other decision-makers on the relative efficacy of treatment options for men with mHSPC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Susan Feyerabend, Fred Saad, Tracy Li, Tetsuro Ito, Joris Diels, Suzy Van Sanden, Peter De Porre, Julie Roiz, Seye Abogunrin, Maria Koufopoulou, Karim Fizazi,